Applications of 17Beta-Hydroxy-17-Methylandrosta-4,9(11)-Dien-3-One in Industrial Manufacturing

Our facility supplies 17Beta-Hydroxy-17-Methylandrosta-4,9(11)-Dien-3-One to licensed manufacturers in specialized markets, focusing on traceable, quality-driven industrial processes. Below are verified downstream sectors and detailed use cases based on standard industry practice.

1. Active Pharmaceutical Ingredient (API) Synthesis for Corticosteroid Manufacturing

Pharmaceutical manufacturers use 17Beta-Hydroxy-17-Methylandrosta-4,9(11)-Dien-3-One as an advanced steroid intermediate in the synthesis of various corticosteroids. Its precise molecular configuration enables targeted C-17 and C-11 modifications, supporting controlled construction of finished molecules. GMP facilities source this material for regulated, large-batch reactions. The compound enters the stream after initial fermentation steps as a key precursor, undergoing selective oxidation, reduction, and acylation depending on the desired corticosteroid (such as dexamethasone or betamethasone). Strict adherence to validated cleaning, documentation, and traceability guides lot release for systemic or topical pharmaceuticals.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, ICH Q7)
• European Pharmacopoeia Monographs for steroidal APIs
• US FDA 21 CFR Part 210/211
• ChP (Chinese Pharmacopoeia) relevant sections

Typical usage ratio

• Varies between 0.5–7% of the API batch volume, depending on conversion yield and end-API structure; ratio adjusted after pilot scale-up to ensure >98% conversion.

Downstream process integration

• Enters post-fermentation purification as the key intermediate;
• Used directly in controlled chemical transformations—mainly ketone reduction and enolization—before final crystallization and micronization, then passed to API formulation step.

Final product types

• Bulk dexamethasone, betamethasone, and related corticosteroid API powders;
• Finished pharmaceutical tablets, ointments, injectables (after further downstream processing).

2. Intermediate for Veterinary Hormone Production

Veterinary pharmaceutical companies utilize this compound as a synthetic building block for anabolic steroid preparations. Specialized animal health plants incorporate it in multistep syntheses where precise side-chain modifications yield species-specific veterinary actives. The material supports the manufacture of hormones administered for growth promotion and reproductive control in regulated markets. Controlled facilities introduce this raw material following primary hydrolysis or acetylation to enable downstream rearrangements, which ensure selectivity in the final formulation for oral, implant, or injection delivery in food and companion animals.

Industry compliance standards

• VICH GL24 for Veterinary Drug Residues
• EU Regulation (EC) No 470/2009 for veterinary drugs
• US FDA CVM Guidance for Industry #206
• GMP for Veterinary Drugs (China)

Typical usage ratio

• 0.3–5% in total synthesis mixtures; ratios reviewed during product registration to meet MRL (maximum residue limit) requirements for each species and administration route.

Downstream process integration

• Incorporated after initial extraction and saponification;
• Processed through specific methylation, oxidation, or condensation steps before final purification and quality control release for veterinary actives.

Final product types

• Injectable anabolic steroid solutions for cattle and swine;
• Controlled-release hormonal implant pellets;
• Oral suspensions for growth modulation in livestock.

3. Synthesis of Anti-Inflammatory Agents in Specialty Bulk Chemicals

Specialty chemical manufacturers involved in producing precursors for anti-inflammatory agent supply chains apply this compound to streamline complex steroidal frameworks. In these facilities, it serves as a functionally advanced intermediate integrated into multi-stage processes demanding high regioselectivity. Chemical engineers introduce the material during post-alkylation batch operations, where it enables precise formation of double and triple bonds essential to targeted anti-inflammatory compounds. Quality control teams monitor residual solvents, isomer content, and batch consistency before release to downstream pharmaceutical or research enterprises.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006
• ISO 9001:2015 for quality management in chemical production
• Specific customer-driven technical specifications for steroidal intermediates
• GHS chemical labeling requirements

Typical usage ratio

• Batch insert concentrations range from 0.8% to 6%, controlled by stoichiometric calculations for targeted derivative output; fine-tuned based on analytical HPLC yield estimates.

Downstream process integration

• Added post-alkylation or initial condensation in batch reactor trains;
• Feeds into catalytic reduction or selective hydrogenation units prior to solvent exchange and final crystallization.

Final product types

• High-purity steroidal intermediates for anti-inflammatory drugs;
• Bulk chemical precursors for further pharma or research applications.

4. Research and Reference Standard Material for Analytical Laboratories

Accredited analytical reference laboratories and pharmaceutical quality control teams source this compound in microbatches as a certified calibration or identity standard. Laboratories integrate it in analytical method development, including HPLC, GC-MS, and NMR, for specificity profiling of finished APIs and steroidal substances. The material also enables spike-in endpoints for bioequivalence studies during regulatory submission of new drug entities. Consistent batch purity and quantification are essential to calibrate instruments and verify absence or presence of the compound in complex test matrices.

Industry compliance standards

• ISO/IEC 17025 Laboratory Competence Standard
• USP and EP Reference Standards requirements
• OECD Guidelines for Testing of Chemicals (where applied in toxicological research)
• SOP for analytical calibration materials

Typical usage ratio

• Applied at 0.01–0.5 mg/mL in calibration and spike solutions, adjusted according to sensitivity of detection method and sample matrix being analyzed.

Downstream process integration

• Weigh-in and dissolution under validated conditions for standard solution preparation;
• Directly injected or spiked into analytical columns, tissues, or biological fluids for quantitative or qualitative testing procedures.

Final product types

• Certified analytical calibration kits for pharma QC labs
• Reference sample archives used in in-house or regulatory laboratories
• Bioanalytical assay validation panels for new drug development